The p53 tumor suppressor gene was found to play a role in the differentiation of several tissue types. We report here that p53-dependent apoptosis plays a role in the final stages of physiological differentiation of normoblasts, resulting in nuclear condensation and expulsion without cell death. Blood samples of healthy newborns, cord blood as well as bone marrow, were analysed for apoptosis by TUNEL and p53 expression by immunostaining. While some samples exhibited simultaneously several distinct patterns of apoptosis, such as perinuclear, diffused nuclear or nuclear apoptotic bodies, others presented a single defined pattern. Overexpression of p53 protein was detected in normoblasts exhibiting either perinuclear or diffused nuclear p53, corresponding to the nuclear apoptotic pattern in the same sample. Similar results were also evident with colonies cultivated for 12-14 days in culture. Differentiated erythroid colonies exhibited overexpression of p53 and positive TUNEL staining only in the normoblasts. We further examined the state of caspase 3/7 and observed a decrease of this activated enzyme during erythroid differentiation in culture. This study suggests a novel role for apoptosis in normoblast differentiation where nuclear degradation occurs with a delay in the actual cell death. A pivotal role for the p53-dependent apoptosis in the erythroid lineage development is implied. However, this apoptotic process is not fully executed because of the exhaustion in caspase 3/7 and thus cells are diverted towards final stages of differentiation.
Introduction
Erythropoiesis is a multistep process consisting of proliferation and differentiation of erythroid precursor cells and, most strikingly, resulting in mature anucleated red blood cells. Morphological and biochemical changes of erythroid cells are important features of this process and the mechanisms underlying most of them are still not clear (Wintrobe, 1999) . Koury and Bondrant (1990) observed that apoptosis is a major component of normal erythropoiesis, and that erythropoietin promotes erythroid precursor cell survival by inhibiting apoptosis. Erythroid cells were found to vary in their sensitivity to erythropoietin, resulting in survival or death of these cells, a mechanism that controls erythrocyte production (Kelley et al., 1993) . Once the red cell mass is restored to normal, the decrease of erythropoietin levels leads to a rapid turn-off of erythropoiesis by allowing apoptosis to occur. It was also demonstrated that erythropoietin functions to suppress apoptosis by maintaining the expression of Bcl-X L and Bcl-2 Silva et al., 1996) . A nonapoptotic role for active caspase 3, probably by mediating the cleavage of proteins involved in nucleus integrity and chromatin condensation, was suggested to be essential for erythroid differentiation (Zeuner et al., 1999; Zermati et al., 2001) .
Tissue homeostasis, proliferation, differentiation and apoptosis are inter-related. The ensuing process depends on the tissue type and whether the process is part of embryonic development or senescence. In the case of red blood cells, it is associated with senescence, resulting in a limited lifespan of the cells.
The role of p53 in the apoptotic response to genotoxic stress is well established (Yonish-Rouach et al., 1991; Kastan, 1996; Polyak et al., 1997) . Less, however, is known about its possible role in the process of apoptosis and differentiation in normal development. It should be noted that p53 expression was detected during embryonic development (Mora et al., 1980; Chandrasekaran et al., 1981; Rogel et al., 1985; Louis et al., 1988; Schmid et al., 1991; Almog and Rotter, 1997; Frenkel et al., 1999) , and was found to participate in the differentiation of several cell types, such as B lymphocytes (Aloni-Grinstein et al., 1993; Zauberman et al., 1995) , muscle cells, keratinocytes (Rehberger et al., 1997) and spermatocytes Schwartz et al., 1993 Schwartz et al., , 1999 ).
These observations prompted us to investigate a possible role of p53 in normoblast differentiation -an advanced stage of erythropoiesis.
In our study, we detected by using TUNEL staining distinct steps in the nuclear apoptotic process in normoblasts. This may precede nuclear condensation and expulsion prior to the appearance of anucleated mature erythrocytes. The same sample revealed p53 overexpression at nuclear sites similar to those of apoptosis. These results were obtained from both peripheral blood samples and in vitro cultured erythroid colonies. Previous studies, showing the involvement of active caspase 3/7 in erythroid cell differentiation (Zeuner et al., 1999; Zermati et al., 2001) , prompted us to determine active caspase 3 in the various phases of differentiation cells in cultures and correlate it with p53 overexpression. We observed a gradual decrease in active caspase 3/7 with the lower level at the final stage of differentiation that coincided with the overexpression of p53 and TUNEL staining. These findings suggest that a reduction in caspase 3/7 activity during the differentiation of erythroid cells prevents the completion of the p53-dependent apoptotic pathway. The possibility that nuclear apoptosis during differentiation may be of a different nature to conventional cell apoptosis is discussed.
Results
To decipher the relation between p53 and differentiation-associated apoptosis of normoblasts, we focused our study on cord and newborn blood samples found to contain this cell population, with no known clinical pathology. Erythroid colonies derived from CD34 þ cells were also studied. Apoptosis was detected by TUNEL staining and p53 expression was determined by immunocytochemistry with DO-1 anti-p53 antibody. This approach was expected to indicate concomitantly distinct cellular localization of these two events.
Apoptosis in normoblasts
Typical morphological changes occurring during erythroid differentiation prompted us to search for a possible involvement of a p53-dependent apoptosis. To that end, we studied TUNEL staining in differentiating erythroid cells. Some samples showed a single type of apoptotic pattern whereas others exhibited several types of apoptotic staining in one given sample. Figure 1 depicts typical TUNEL staining of normoblasts of cord and newborn blood. Figure 1a is a cord blood sample with simultaneous expression of several patterns of the TUNEL staining. In this sample, we observed cells with only perinuclear rings, cells with a perinuclear as well as a diffused nuclear staining, cells with an intensive nuclear staining and cells that represent apparently the final step of nuclear apoptosis manifested by the existence of nuclear apoptotic bodies. This may represent different and defined steps in the DNA degradation of the nucleus and its eventual condensation.
In other samples of cord blood and newborns (four are depicted in Figure 1b 
p53 Expression in normoblasts
Next, we determined the expression of p53 during erythroid cell differentiation. Figure 2 depicts TUNEL and p53 staining in different slides of the same sample. Figure 2a represents two cord blood samples and Figure 2b , two samples of newborns. In each of these samples, apoptosis and p53 overexpression were detected at the same nuclear sites. As depicted in Figure 2 , overexpression of p53 in the normoblasts occurred as a perinuclear ring similar to the TUNEL staining (Figure (2aI, II) , and in others p53 accumulation and TUNEL were diffused in the condensed nucleus as well ( Figure  2bI , II). It should be noted that no consistent staining patterns were associated with the samples obtained either from cord or newborn blood. The same TUNEL staining and p53 expression patterns were obtained in 
Caspase 3/7 in erythroid cell cultures
The observation that cells exhibited positive TUNEL staining, indicative for apoptosis, but yet remained vital, prompted us to investigate a downstream event in the process of apoptosis. Such a candidate is caspase 3/7
For that purpose, we determined active caspase in both erythroid colonies and in erythroid cells grown in liquid culture. The results of active caspase 3/7 in erythroid cultures are depicted in Figure 5 (a-d). As seen, a distinct decrease in active caspase 3/7 was observed along with the progression of erythroid maturation (Figure 5a-d) . After 7 days of culture, almost all the erythroid cells were positive for caspase 3/7 as measured by flow cytometry (Figure 5a, b) . The continuous decrease was observed till day 14 of cell harvesting both in colonies and liquid culture. It should be noted that on this day p53 was overexpressed in the normoblasts (see Figure 4 ). The decrease was more gradual in colonies because of the homogenous cell constitute of this culture 
Discussion
Apoptosis seems to play different roles in proliferation or in differentiation of erythropoiesis. Each apoptotic pathway leads to a different outcome. As previously shown, apoptosis controls homeostasis of red cell lineage by balancing survival and death of precursor cells using the well-described apoptotic pathway (Koury and Bondrant, 1990) . A second role for apoptosis in normoblast differentiation can be deduced from our own studies, whereby only nuclear degradation and condensation take place and cell death is delayed. Apoptosis in normoblasts was found to be p53-dependent leading to the development of intact mature anucleated erythrocytes. This process of 'programmed nuclear death', as manifested here by TUNEL staining of the normoblasts, seems to have defined steps. We would like to suggest a scenario whereby the process of DNA degradation starts in the perinuclear region, diffusing all over the nucleus and as in 'programmed cell death', nuclear apoptotic bodies are eventually formed. However, in this case, a mature erythrocyte is formed following nuclear expulsion and cell death is postponed. The localization of the p53 protein and the TUNEL staining, in a given sample, was found in the same nuclear site, suggesting a p53-dependent apoptotic pathway. Interestingly, p53 seems to be expressed throughout the nuclear apoptotic process. This was further substantiated by using erythroid colonies derived from CD34 cells. Among the differentiating erythroblasts harvested on day 11 or 14, overexpression of p53 and positive TUNEL were exhibited only in the normoblasts. TUNEL positively in this case was not a result of cell death, since cell viability exceeded 85%. A study on Syrian hamster yolk-sac-derived erythroid cells also detected TUNEL staining in the final stages of differentiation without nuclear fragmentation (Morioka et al., 1998) . It was intriguing to observe that caspase 3/7, an active player in the apoptotic pathway, downstream to p53 is expressed early in the differentiation process and is probably employed in a nonapoptotic differentiation mechanism (Zermati et al., 2001) . In our experiments, it was found that caspase 3/7 activity is the lowest when p53 is overexpressed at the final stage of erythroid differentiation.
It is, nevertheless, still unclear whether other apoptotic events associated with normal erythropoiesis are p53-dependent. It was previously shown that in Epodependent preleukemic proerythroblasts, the FVA cells, apoptosis was not associated with a specific cell cycle nor did it affect the stabilization of the p53 protein (Kelley et al., 1994) . In another study, it was demonstrated that p53 was not required for cell survival, growth arrest during differentiation or induction of apoptosis in FVA cell line (Kelley et al., 1998) . These studies, however, were carried out on erythroid cell lines and further studies are required to determine whether this reflects the actual involvement of p53 in normal proerythroblast development in vivo. A study on erythroid colonies derived from CD34 þ cells suggested that wild-type p53 and RB are proliferation suppressor genes that interfere with normal maturation of hematopoietic cells (Mahdi et al., 1996) . These results contradicted previous ones obtained in normal human bone marrow cells, demonstrating detectable levels of p53 protein in the nonproliferative mature lymphoid, granulocytic and monocytic cell populations. This suggested that wild-type p53 may play a role in hematopoietic cell maturation, possibly by contributing to the inhibition of proliferation that occur during terminal differentiation (Kastan et al., 1991) . The latter results are in agreement with our observation of the present study, demonstrating overexpression of p53 during terminal differentiation of erythroid cells.
p53 was found to participate in a number of cell differentiation pathways mediated by several molecular mechanisms. For example, in the case of B-lymphocyte differentiation, it was suggested that p53 directly transactivates promoter sequences of the immunoglobulin genes (Aloni-Grinstein et al., 1993; Zauberman et al., 1995) . In the case of keratinocytes, the ratio between two alternatively spliced p53 forms controls the process of differentiation (Rehberger et al., 1997) . In spermatogenesis, p53 expression was shown to be associated with DNA repair Schwartz et al., 1993 Schwartz et al., , 1999 .
Our present study on normoblast differentiation describes yet another mechanism of p53-dependent differentiation, via apoptosis. In this case, because of limited amounts of caspase-3, nuclear apoptosis occurs without the final eradication of the cells. This conclusion is further substantiated by the observation that healthy newborns and cord blood exhibit erythrocytosis and a low number of normoblasts. If cell apoptosis at the normoblast stage of erythropoiesis would serve as a mechanism that controls homeostasis, then a higher number of normoblasts and normal counts of erythrocytes would be expected. Furthermore, our observation that nuclear apoptosis of normoblasts occurred in all bone marrow samples examined and in viable normoblasts in erythroid colonies also supports the conclusion that this is a step in differentiation and not in the final cell destruction. Therefore, it is anticipated that while nuclear apoptosis leads to physiological maturation of normoblasts, massive erythroid cell apoptosis would result in pathologies, such as different anemias. This raises intriguing possibilities as to the status of the p53 protein expression in diseases characterized by pathological states of erythropoiesis. In polycythemia vera, a disease characterized by erythrocytosis, erythroid precursors survive in vitro in the absence of erythropoietin and differentiation is accelerated. The erythroid cells at all stages express Bcl-X L , a repressor of apoptosis (Silva et al., 1998) . Interestingly, in b-thalassemia, major erythroid precursors undergo accelerated programmed cell death, which may explain the decrease in mature erythrocytes in this disease (Yuan et al., 1993; Aljurf et al., 1996) . Results obtained with folate-deficient mice further emphasizes the central role of apoptosis in balancing survival and death of erythroid cells (Koury et al., 1997) . This type of control may occur at any stage of impaired erythroid differentiation. It was demonstrated that folate-deficient in vitro erythropoiesis showed an increased rate of apoptosis at late stages of erythroid differentiation following p53 and p21 accumulation. This was suggested to underlie the pathology of megaloblastic anemia (Koury et al., 1997) . Erythroleukemia is characterized by abrogation of the differentiation pathway and accumulation of erythroid precursors. For example, the exposure of HEL and K562 leukemic cell lines to differentiation inducers resulted in erythroid differentiation, associated with downregulation of Bcl-X L and the onset of apoptosis. This suggests that apoptosis and erythroid differentiation proceed simultaneously, but can be separated by Bcl-X L in human leukemia cells . The erythroid leukemic cell line K562 harbors a mutation in the p53 gene (Law et al., 1993) . This mutation is a single-base insertion leading to an N-terminal truncated protein of 147 amino acids, and results in a defect in normal differentiation and apoptosis of these leukemic cells. The inducers of differentiation may exert their activity in this case via a p53-independent pathway. Furthermore, it was demonstrated in KO p53 knockout mice (Wlodarski et al., 1998 ) that recovery after cytotoxic treatment, that is, lineage commitment and differentiation of hematopoietic progenitors, appeared to be independent of p53 status. This also raises the possibility that p53-dependent processes of differentiation can be replaced by alternative p53-independent pathways, or that other members of the p53 gene family participate in the normoblast differentiation pathway.
Our present study demonstrates a unique apoptotic process affecting only the nucleus, and generating an intact mature red blood cell. Conventional apoptosis during cell proliferation is well characterized by distinctive cellular and molecular events. p53-dependent apoptosis during erythroid differentiation, described here for the first time, may be of a different nature. In this case, a stepwise degradation involves the nucleus without destroying the whole cell. This may occur as a result of caspase exhaustion in a parallel nonapoptotic differentiation pathway.
Based on our results we would like to propose a model, whereby multiple changes in the membrane, cytoplasm and nucleus during erythroid differentiation induce p53 expression at the final stage of differentiation to execute cell death. p53 triggers the apoptotic machinery but it could only partly be completed because of exhaustion of active caspase 3/7 in a parallel differentiation procedure. The result of these two apparently antagonistic pathways yields nuclear apoptosis with a delayed cell death.
This process may be a paramount p53-dependent event in the final stage of erythroid differentiation.
Materials and methods
Blood smears were prepared from 12 samples of cord blood, two samples of peripheral blood of newborns and 13 samples of bone marrow and were stained with May-GrunwaldGiemsa to assess the presence of normoblasts.
Cord blood samples were either of term pregnancies or of different stages of pregnancies (second and third trimester). Care was taken to exclude bone marrow samples of patients with hematological malignancies or receiving chemotherapy.
Human cell preparation and CFU assay
Human cord blood (CB) samples were obtained from full-term deliveries after informed consent and were used in accordance with the procedures approved by the human experimentation and ethics committee of the Weizmann Institute. The procedure was carried out as described before (Kollet et al., 1999) ; briefly, the blood samples were diluted 1:1 in phosphatebuffered saline (PBS) without Mg 2 þ /Ca 2 þ , supplemented with 10% fetal bovine serum (FBS). Low-density mononuclear cells were collected after standard separation on Ficoll-Paque (Pharmacia Biotech, Uppsala, Sweden), and washed in RPMI with 10% FBS. Enrichment of CD34
þ cells was performed with autoMACS separation apparatus (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer's instructions. The purity of the enriched CD34 þ cells was greater than 85%.
Freshly isolated CB CD34 þ cells (1000-4000 cells/ml) were plated in 0.9% methylcellulose (Sigma), 30% FCS, 50 ng/ml SCF, 5 ng/ml IL-3, 5 ng/ml GM-CSF (R&D systems) and 2 U/ ml erythropoietin (Orto Bio Tech, Don Mills, Canada) . The cultures were incubated at 371C in a humidified atmosphere containing 5% CO 2 . Erythroid colonies were plucked on days 11 and 12 according to morphologic criteria. Viability determined by trypan blue exclusion was between 85 and 90%. Colonies were washed once with PBS and resuspended.
p53-Dependent apoptosis in normoblast differentiation S Peller et al Slides were prepared for Giemsa staining, p53 expression and TUNEL. To detect, the differentiating normoblasts were also stained for HbF by the method of Betke-Kleihauer (Betke and Kleihauer, 1967) .
Immunocytochemical staining of p53
Blood smears with normoblasts were also stained for the p53 protein as previously described (Peller et al., 1998) . Briefly, the slides were fixed in methanol at À201C for 15 min, washed three times with 0.005 m TBS (Tris-buffered saline, pH 7.6), and incubated overnight at 41C with a monoclonal anti-p53 (DO-1, monoclonal supernatant). Each slide was washed 3 Â with TBS, drained, and incubated with 50 ml 1 : 10 dilution in TBS of goat anti-mouse (Sigma M4155) for 30 min, washed three times with TBS and incubated for 30 min with 50 ml of a 1:40 dilution of APAAP mouse monoclonal (Sigma A7827), and washed three times with TBS. The slides were incubated again with goat anti-mouse and APAAP antibody for 15 min each time. All incubations were carried out at room temperature. The slides were stained for 30 min with naphthol AS-MX phosphate and Fast violet (Sigma Chemical Co., St Louis, MO, USA) for 3 min. Control slides whereby DO-1 was substituted by buffer were stained simultaneously with each sample.
Apoptosis
This was measured by the TUNEL staining as previously described (Frenkel et al., 1999) . Briefly, slides were fixed for 15 min in methanol at À201C. After a wash with DDW, endogenous peroxidases were inactivated by incubating the slides with 2% H 2 O 2 in PBST (PBST, with 0.05% Tween 20) for 10 min at room temperature. Slides were then incubated in TdT buffer (Boehringer Mannheim) for 5 min at room temperature, and then the reaction mixture (5 Â TdT buffer, 1 ml biotin -21 -dUTP (Clontech, 1 mm stock), and 8 U of TdT enzyme (Boehringer Mannheim) in total volume of 50 ml) was added. The reactions were carried out at 371C for 1.5 h in a humid chamber. The slides were washed with 2 Â SSC, DDW and finally with PBS, and covered with 10% SM in PBST for 15 min. After SM was removed, the slides were incubated with ABC solution from ABC kit (Vector Laboratories, Inc.) for 30 min at room temperature, washed with PBS and stained using the AEC procedure (Sigma). The slides were then washed 3 Â in DDW and stained with hematoxyilin for 30 s and mounted with Kaiser's glycerol gelatin (Merck).
Determination of caspase 3/7
Caspase 3/7 was determined by two methods. The Apo-ONE Homogenous Caspase -3/7 Assay (Promega Corporation, WI, USA) was used to determine the activity of caspase 3/7 in lysates of samples of 50-100 Â 10 3 cells collected at various days of culture, using Z-DEVD-R110 as a substrate. The results were calculated as fluorescence/min/cells and depicted as a decrease of caspase activity.
The second method determined the percentage of cells, collected at various days of erythroid culture, containing active caspase 3/7 by using the in situ FLICA Caspase 3/7 detection kit (Chemicon International, Inc., CA, USA). This kit uses a carboxyfluorescin-labeled fluoromethyl ketone peptide inhibitor of caspase-3 (FAM-DEVD-FMK), which produces green fluorescence. The percentage of caspase-positive cells were determined by EPICSII flow cytometer (Coulter-Beckman, USA).
